# Altaire Pharmaceuticals, Inc. – FDA Inspection, Mar 19, 2012

Source: https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/f974de5b-1ab5-4777-99fc-699c1aff0b56
Source feed: FDA_Inspections

> FDA inspection 772796 of Altaire Pharmaceuticals, Inc., March 19, 2012. Classification: Voluntary Action Indicated (VAI). 10 citations under 21 CFR parts 111 and 211. 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 772796
- Company Name: Altaire Pharmaceuticals, Inc.
- Inspection Date: 2012-03-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 10

## Related Documents

- [FDA Inspection 1314330 - 2026-04-21](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/41e19a6e-ba33-47a8-ad24-842a94d518b4)
- FDA Inspection 1251507 - 2024-10-21
- [FDA Inspection 1162640 - 2022-02-11](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/0c20c70c-b178-4306-8b90-55ba5c3ee376)
- [FDA Inspection 1089315 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/b7371309-8de4-43de-bec3-fb911cfa0240)
- [FDA Inspection 1005208 - 2017-03-09](https://www.keypedia.com/records/fda_inspections/altaire-pharmaceuticals-inc/f51d435b-4a99-4725-821e-eb2163b6329a)

Company: https://www.keypedia.com/companies/altaire-pharmaceuticals-inc/1e892910-1e24-4697-87c3-61cc48735f49

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c